Stomach cancer that reaches the liver is considered advanced, and for most people treatment aims to control the disease for as long as possible rather than cure it. But it is not one single situation. How many liver spots there are, and whether the cancer has spread anywhere else, can change the plan from drug treatment alone to surgery that offers a real chance of long-term survival. For a minority of carefully chosen people, about 1 in 4 to 1 in 3 are alive five years after having the spots removed.
What It Means When Cancer Shows Up in the Liver
When cancer moves from the stomach to the liver, the tumors there are still stomach cancer, not liver cancer. Blood leaving the stomach flows through the portal vein into the liver before it reaches the rest of the body, so the liver gets the first look at any cells that break away.
Because the liver spots carry the stomach tumor’s features, treatment uses stomach cancer drugs. Your reports may say “hepatic metastases,” and hepatic simply means liver.
Liver spread can be found at diagnosis or months or years after treatment. For stomach cancer, survival was similar either way, with about 4 in 10 people alive one year after liver spread was found.1Journal of the Korean Gastric Cancer Association. Clinicopathologic Features and Difference in Prognosis in Synchronous and Metachronous Hepatic Metastases of Gastric Cancer
Many people with liver spots feel nothing specific, and the spread turns up on a scan. Larger spread can cause discomfort on the right side of the belly, tiredness, or weight loss. Yellow skin or eyes (jaundice) is a sign to report to the care team promptly.
Stage IV describes where the cancer is, not how fast it will move. Some people live far longer than averages suggest, and others less. The label alone doesn’t decide treatment; the number of liver spots, any other organs involved, and general health shape the plan. When liver spread is found at diagnosis, there is usually a pause before any operation so the team can map the full extent with scans.
How Doctors Find and Measure Liver Spread
A CT scan is usually the first test used to check the liver. After that, other imaging can add detail. An MRI with a liver-specific contrast dye found about 9 in 10 liver spots, while a PET/CT scan found about 3 in 4.2Journal of Nuclear Medicine. Value of Retrospective Fusion of PET and MR Images in Detection of Hepatic Metastases: Comparison with 18F-FDG PET/CT and Gd-EOB-DTPA–Enhanced MRI Combining PET and MRI images found slightly more spots and gave doctors more confidence about spots larger than 1 cm.3Journal of Nuclear Medicine. Value of Retrospective Fusion of PET and MR Images in Detection of Hepatic Metastases: Comparison with 18F-FDG PET/CT and Gd-EOB-DTPA–Enhanced MRI
The exact count matters before surgery. The number and size of spots decide whether an operation is even considered, and a missed small spot can mean the cancer returns quickly afterward. If surgery is being discussed, ask whether a liver MRI is planned.
Spread to the belly lining often hides on scans, so surgeons may do a keyhole look inside the belly (laparoscopy) to check. Finding it usually rules out liver surgery.4PubMed Central. Comparing PET/MRI with PET/CT for Pretreatment Staging of Gastric Cancer
A liver MRI with contrast takes longer than a CT, often thirty minutes to an hour, with repeated short breath-holds inside a narrow machine. The dye goes in through a vein, and the team will ask about kidney problems and allergies beforehand. Scans rarely give a perfect answer, and a spot too small to judge may be rechecked in a few weeks.
Blood tests help too. Blood markers called CEA and CA19-9 are often checked, and lower levels went along with better survival after liver surgery.5PubMed. Long-term survival after liver metastasectomy in gastric cancer: Systematic review and meta-analysis of prognostic factors A newer blood test measuring tumor DNA in the bloodstream tends to show higher levels when the liver is involved and can track whether treatment is working.6PubMed Central. The Role of ctDNA in Gastric Cancer
Limited Spread Versus Widespread Disease
Limited spread means only a few spots in one organ.7PubMed Central. Oligometastasis of Gastric Cancer: A Review For the liver, one European definition counts up to three spots in one side of the liver, or two spots across both sides.8PubMed Central. Oligometastasis of Gastric Cancer: A Review Some doctors use a slightly looser rule of up to three liver spots anywhere.9PubMed Central. Long‐term treatment outcomes in gastric cancer with oligometastasis These definitions are guides for discussion rather than fixed cutoffs, and a team can still consider surgery for someone just outside them. A case near the edge is often reviewed at a tumor board meeting, where surgeons, oncologists, and radiologists look at the scans together.
Certain features predict a better outcome. Better outcomes went with three or fewer spots, all on one side of the liver, and the largest under 5 cm.10PubMed. Long-term survival after liver metastasectomy in gastric cancer: Systematic review and meta-analysis of prognostic factors Having no cancer on the belly lining was one of the strongest signs of a better outlook.11PubMed. Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer A smaller original stomach tumor with fewer lymph nodes involved also helped.12PubMed. Long-term survival after liver metastasectomy in gastric cancer: Systematic review and meta-analysis of prognostic factors
Before spread is called limited, doctors look beyond the liver, usually with chest and belly scans, for other spots in the lungs, bones, or lymph nodes. Cancer in lymph nodes far from the stomach counts differently from nodes right beside it, which is one reason to ask exactly where any nodes are.
It helps to bring specific questions about your own scans. How many liver spots are there, and how large is the biggest? Are they on one side of the liver or both? Is there any spread to the belly lining, lungs, or distant lymph nodes? And does this count as limited spread at this hospital?
Surgery to Remove Liver Tumors
Among carefully chosen people who had liver spots removed, about 22 to 29 in 100 were alive five years later.13PubMed. Long-term survival after liver metastasectomy in gastric cancer: Systematic review and meta-analysis of prognostic factors Half of those patients lived longer than about 31 months,14PubMed. Surgical treatment of gastric cancer liver metastases: Systematic review and meta-analysis of long-term outcomes and prognostic factors and about 1 in 10 was alive after ten years.15PubMed. Long-term survival after liver metastasectomy in gastric cancer: Systematic review and meta-analysis of prognostic factors These results come only from people without cancer beyond the liver.16PubMed. Surgical treatment of gastric cancer liver metastases: Systematic review and meta-analysis of long-term outcomes and prognostic factors Only people healthy enough, with limited spread, get surgery, so these results look better than the average and can’t be applied to everyone with liver spread.
The operation usually removes the stomach tumor and nearby lymph nodes along with the liver spots. A healthy liver can regrow tissue after part of it is removed. Recovery often takes several weeks in and out of hospital. Major surgery carries real risks such as bleeding, infection, and trouble healing, and these rise with age and other health problems. Even after a clean operation the cancer can come back, often in the liver or elsewhere, which is why follow-up scans continue for years. Whether to operate balances possible gain against the strain of recovery, and it is fair to ask the surgeon how many of these operations they do.
Timing of chemotherapy matters. Surgery alone first, then chemotherapy, did not help survival in widespread disease compared with chemotherapy alone.17International Journal of Gastrointestinal Intervention. The role of surgery in gastric cancer with liver metastases: A narrative review But chemotherapy first, then surgery, extended median survival to about 23 months versus about 11 months with chemotherapy alone in one trial.18International Journal of Gastrointestinal Intervention. The role of surgery in gastric cancer with liver metastases: A narrative review Chemotherapy after surgery was also linked to longer survival.19PubMed. Long-term survival after liver metastasectomy in gastric cancer: Systematic review and meta-analysis of prognostic factors20PubMed Central. Surgery Strategies for Gastric Cancer With Liver Metastasis
Sometimes cancer first judged inoperable shrinks enough on drug treatment to be removed, and then operated on.21PubMed Central. Successful conversion surgery for stage IV gastric cancer with liver metastases after second-line chemotherapy with ramucirumab and paclitaxel: a case report People who had it lived a median of about 30 months versus 11 months for chemotherapy alone.22PubMed Central. The long-term survival of stage IV gastric cancer patients with conversion therapy When no cancer was left at the cut edges, median survival reached about 41 months.23PubMed Central. The long-term survival of stage IV gastric cancer patients with conversion therapy
Treating the Liver Directly Without Major Surgery
Ablation uses a needle and heat to destroy small tumors.24PubMed. Prospective study of arterial infusion chemotherapy followed by radiofrequency ablation for the treatment of liver metastasis of gastric cancer Chemotherapy delivered straight into the liver artery shrank tumors to 3 cm or less, after which ablation destroyed the remaining spots in a small group.25PubMed. Prospective study of arterial infusion chemotherapy followed by radiofrequency ablation for the treatment of liver metastasis of gastric cancer Combining chemoembolization, which blocks the tumor’s blood supply, with ablation kept about half of people with gut-cancer liver spots alive at two years.26PubMed. Radiofrequency ablation combined with transarterial chemoembolization for liver metastases from gastrointestinal cancers These approaches work best on smaller tumors.27PubMed. Radiofrequency ablation combined with transarterial chemoembolization for liver metastases from gastrointestinal cancers
They are often used when surgery is too risky or the spots are hard to reach. They treat only the liver, not cancer elsewhere, so they are usually combined with drug treatment. Availability varies by hospital, so ask about specialist centers.
For ablation, the doctor guides a thin needle into the tumor using ultrasound or CT, so it can often be done through the skin rather than through a large cut. Heat at the needle tip destroys the tumor and a thin rim of tissue around it, meant to catch cells just beyond the visible edge. Many people go home the same day or after a short stay, and recovery is usually quicker than after major surgery.
In chemoembolization, a doctor threads a thin tube through an artery, usually from the groin, up to the vessels feeding the liver tumors. Chemotherapy and tiny particles are released there, delivering drug directly to the tumor and cutting off part of its blood supply. The liver gets blood from both the portal vein and the artery, and tumors depend heavily on the artery, which is why this can hurt tumors more than healthy liver.
Drug Treatment for Widespread Liver Spread
First treatment usually combines a platinum drug such as oxaliplatin or cisplatin with 5-FU or capecitabine.28Hirschfeld Oncology. Chemo for stomach cancer: A Practical Guide to Treatment In some people, strong chemotherapy has shrunk liver spots enough for later surgery.29PubMed. Advanced gastric cancer with liver and lymph node metastases successfully resected after induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil
Tumors are also tested for markers that decide which added drugs may work. HER2 is a protein on the surface of some cancer cells, and for HER2-positive cancer, adding trastuzumab was the first targeted drug shown to extend survival.30PubMed Central. Targeted therapies in gastric cancer and future perspectives Claudin 18.2 is another surface protein, and for tumors with high levels of it, adding zolbetuximab to chemotherapy lowered the risk of death by about 23%.31WCM Newsroom. A New Targeted Treatment Shows Promise for Select Patients with Stomach Cancer Half of patients in that trial lived longer than about 14 months, up from about 12.32WCM Newsroom. A New Targeted Treatment Shows Promise for Select Patients with Stomach Cancer The catch is that Claudin 18.2 levels tend to be lower in cancers that spread to the liver.33PubMed Central. Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know?
Ask whether the tumor was tested for the HER2 marker, the Claudin 18.2 marker, and PD-L1. The results guide which added drug fits, and testing can often be done on the original biopsy.
Immunotherapy drugs such as nivolumab are now often combined with chemotherapy as first treatment.34PubMed Central. Conversion surgery for gastric remnant cancer with liver metastasis after nivolumab combination chemotherapy achieving pathological complete response: a case report and literature review Some research found immunotherapy worked less well when the liver was involved,35PubMed Central. Impact of immunotherapy on liver metastasis while other research found lasting responses regardless of liver spread.36PubMed Central. Prognostic characteristics and clinical response to immunotherapy targeting programmed cell death 1 for patients with advanced gastric cancer with liver metastases
Chemotherapy is given in cycles, often every two or three weeks. Scans every few months check whether tumors are shrinking, and treatment may change if the cancer grows.
Platinum-based chemotherapy often causes nausea, tiredness, lowered blood counts, and numb or tingling fingers and toes. Anti-nausea medicines work best taken as scheduled rather than after sickness starts, so ask for a plan before the first cycle. Report a fever promptly, because low white blood cells make infections dangerous.
When the Liver Starts to Fail
Many chemotherapy drugs are broken down by the liver, so standard chemotherapy is usually avoided in severe liver failure.37PubMed Central. Successful treatment with nivolumab in a patient with gastric cancer with severe liver failure resulting from multiple liver metastases: A case report Options remain, though. In one reported case, nivolumab worked in a patient with severe liver failure from many liver spots.38PubMed Central. Successful treatment with nivolumab in a patient with gastric cancer with severe liver failure resulting from multiple liver metastases: A case report In two reported cases, chemotherapy into the liver artery shrank extensive tumors and cleared jaundice.39PubMed. Extensive liver metastasis of gastric cancer effectively treated by hepatic arterial infusion of 5-fluorouracil/cisplatin
The liver clears many drugs and makes proteins the body needs, so when it struggles, drugs can build up and cause more harm. Doctors check liver blood tests, including bilirubin, before each chemotherapy cycle to decide whether it is safe to go ahead. Treatment may be delayed or reduced until the tests improve, if they can.
Jaundice means bilirubin is building up, turning skin and eyes yellow and sometimes causing itching. It may come from tumors crowding out healthy liver, but also from a blocked bile duct, which is a different problem. A blocked duct can sometimes be opened with a small tube called a stent, which may let treatment continue. Contact the care team promptly for yellow skin or eyes, dark urine, or pale stools; a swollen belly or legs; or confusion or extreme sleepiness.
Outlook and Comfort Care
Half of people with stomach cancer and liver spread lived about 9 months or more in one group.40Journal of the Korean Gastric Cancer Association. Clinicopathologic Features and Difference in Prognosis in Synchronous and Metachronous Hepatic Metastases of Gastric Cancer Chemotherapy alone gave a median survival of about 11 months in another group.41PubMed Central. The long-term survival of stage IV gastric cancer patients with conversion therapy More liver spots and more lymph nodes involved went with shorter survival, while treating the liver spots went with longer survival.42PubMed. Prognostic analysis and liver metastases relevant factors after gastric and hepatic surgical treatment in gastric cancer patients with metachronous liver metastases: a population-based study
The two figures come from different groups with different health and treatments, so they can’t be compared directly. Treatment has also changed over the years, so older figures may understate what’s possible today.
Median means half of people live longer than the number, and some live much longer. Your own markers and spread pattern shift the picture.
Palliative care manages pain, nausea, eating problems, and fatigue. It can run alongside cancer treatment, not only at the end, so ask for a referral early.
Surgery can also be aimed at comfort. Removing the stomach tumor to ease symptoms gave more time out of hospital than a bypass operation.43Wiley Online Library (Journal of Surgical Oncology). Therapeutic significance of palliative operations for gastric cancer for survival and quality of life When cancer had spread widely on the belly lining, though, comfort surgery did not help survival or quality of life.44Wiley Online Library (Journal of Surgical Oncology). Therapeutic significance of palliative operations for gastric cancer for survival and quality of life
Removing the tumor can relieve bleeding or blockage, which helps people eat and avoid emergency admissions. A bypass reroutes food around a blockage without removing the tumor, a smaller operation that leaves the tumor in place. Whether either is advised depends on symptoms and how widespread the cancer is, so it is a question for the surgeon.